Status:
COMPLETED
Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
Centre Hospitalier Sud Francilien
Conditions:
Sickle Cell Disease
Eligibility:
FEMALE
18-45 years
Brief Summary
The study consists in collecting umbilical cord blood cells from newborns at risk of sickle cell disease, to perform laboratory experiments aiming to characterize the cells with HbS/HbS mutation, to d...
Detailed Description
Pregnant individuals carrying at least one HbS allele will be included in the study to collect the umbilical cord blood of the child at birth. Collected cells will be used anonymously for genetic and ...
Eligibility Criteria
Inclusion
- Pregnant women, giving birth at CHSF and consenting to the collect and study of placental blood after delivery
- Age 18 to 45 years
- Biological testing of the participant includes hemoglobin electrophoresis and shows at least one HbS allele
Exclusion
- Lack of written consent
- Minors (not 18 years old) or under guardianship
- Diseases : HIV, Hepatitis B, Hepatitis C or HTLV (Human T Leukemia Virus).
Key Trial Info
Start Date :
October 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03876821
Start Date
October 23 2019
End Date
October 23 2023
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHSF
Corbeil-Essonnes, France, 91106